fluorodeoxyglucose f18 has been researched along with Genital Diseases, Female in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alpaugh, RK; Doss, M; Yu, JQ | 1 |
Akin, EA; Kuhl, ES; Zeman, RK | 1 |
Avril, NE; Kohan, A | 1 |
Fanti, S; Marzola, MC; Musto, A; Nanni, C; Rampin, L; Rubello, D | 1 |
4 review(s) available for fluorodeoxyglucose f18 and Genital Diseases, Female
Article | Year |
---|---|
Normal Variants and Pitfalls Encountered in PET Assessment of Gynecologic Malignancies.
Topics: Adult; Aged; Artifacts; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Diseases, Female; Genital Neoplasms, Female; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiographic Image Enhancement; Risk Assessment; Sensitivity and Specificity | 2018 |
The role of FDG-PET/CT in gynecologic imaging: an updated guide to interpretation and challenges.
Topics: Female; Fluorodeoxyglucose F18; Genital Diseases, Female; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Pelvis: normal variants and benign findings in FDG-PET/CT imaging.
Topics: Bone Diseases; Colonic Diseases; Female; Fluorodeoxyglucose F18; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Multimodal Imaging; Pelvic Bones; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Urinary Bladder Diseases | 2014 |
Present and future of PET and PET/CT in gynaecologic malignancies.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Forecasting; Genital Diseases, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |